The U.S. Centers for Disease Control and Prevention (CDC) released a report Thursday detailing three cases of infections believed to be associated with stem-cell treatments received by American patients in Mexico. The infections, caused by non-tuberculous mycobacteria (NTM), are described as difficult-to-treat, intrinsically drug-resistant, and rapidly growing.

Cases Detected in Colorado Hospitals

All three patients, currently under treatment at two Colorado hospitals, contracted the infections following stem-cell injections administered at two separate clinics in the Mexican border state of Baja California, approximately 167 miles apart.

Previous Incidents and Possible Causes

In previous instances, both American and Mexican individuals have been infected, potentially due to the practice of some Mexican doctors drawing multiple doses of anesthetics from a single vial. This practice often arises from shortages or other issues within the healthcare system, though its connection to the recent outbreak remains unclear.

The initial case, reported in late 2022, involved a woman receiving embryonic stem-cell treatment for multiple sclerosis. Subsequently, in spring 2023, two male patients in Colorado were diagnosed with joint infections following stem-cell treatments in Baja California for various forms of arthritis.

CDC Recommendations and Medical Tourism

The CDC’s report underscores the importance of vigilance in identifying similar cases and offers guidance to individuals considering medical tourism. This recommendation is particularly relevant given past incidents where local shortages of morphine and fentanyl prompted anesthesiologists in Mexico to resort to unorthodox practices, such as administering multiple doses from a single vial.

Past Outbreaks and Consequences

In 2022, contaminated anesthetics stemming from similar practices led to a meningitis outbreak in Mexico’s northern state of Durango, resulting in approximately three dozen fatalities, including pregnant women who received epidurals. Similarly, Americans were affected by a meningitis outbreak in 2023 following surgical procedures at clinics in the Mexican border city of Matamoros.

These incidents highlight the potential risks associated with medical treatments abroad and emphasize the need for thorough research and caution when considering such options.

Conclusion: Exercise Caution When Seeking Medical Treatments Abroad

The recent cases of infections linked to stem-cell treatments in Mexico underscore the importance of exercising caution when seeking medical procedures outside one’s home country. While medical tourism can offer access to innovative treatments and cost savings, it also carries inherent risks. Prospective patients should thoroughly research healthcare providers, facilities, and regulatory standards before making any decisions. Additionally, consulting with medical professionals and heeding official advisories, such as those provided by the CDC, can help mitigate potential risks and ensure a safe healthcare experience.

Source